Metraipolis › archive › dc_4289f5352bee

Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: impact of false-positive BD MGIT 960 results and added value of sequencing for accurate… — Europe PMC PMID:42221586

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42221586
DOI
10.3389/fcimb.2026.1777714
License (as archived)
solo-consultazione
Archived
2026-10-08T04:33:53.444Z
SHA-256 of the archived text
fdc980af0496b0c6f9d96146e680d94f878c35fe42c579a9512da30fa479b96d
Stable URL of this page
https://metraipolis.com/documento/dc_4289f5352bee

How to cite

Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: impact of false-positive BD MGIT 960 results and added value of sequencing for accurate… — Europe PMC PMID:42221586 — Europe PMC (en), https://europepmc.org/article/MED/42221586 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4289f5352bee (Metraipolis archive dc_4289f5352bee, sha256 fdc980af0496b0c6f9d96146e680d94f878c35fe42c579a9512da30fa479b96d)
BibTeX
@misc{dc4289f5352bee,
  title = {Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: impact of false-positive BD MGIT 960 results and added value of sequencing for accurate… — Europe PMC PMID:42221586},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42221586},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4289f5352bee; sha256 fdc980af0496b0c6f9d96146e680d94f878c35fe42c579a9512da30fa479b96d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42221586. Agents can read the archived copy with the MCP tool read_document.